Sight Sciences, Inc. (SGHT)
SGHT Stock Price Chart
Explore Sight Sciences, Inc. interactive price chart. Choose custom timeframes to analyze SGHT price movements and trends.
SGHT Company Profile
Discover essential business fundamentals and corporate details for Sight Sciences, Inc. (SGHT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
15 Jul 2021
Employees
216.00
Website
https://www.sightsciences.comCEO
Paul Badawi
Description
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
SGHT Financial Timeline
Browse a chronological timeline of Sight Sciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.15, while revenue estimate is $21.69m.
Earnings released on 6 May 2026
EPS came in at -$0.24 falling short of the estimated -$0.19 by -26.32%, while revenue for the quarter reached $19.70m , beating expectations by +6.68%.
Earnings released on 4 Mar 2026
EPS came in at -$0.08 surpassing the estimated -$0.15 by +46.67%, while revenue for the quarter reached $20.39m , beating expectations by +0.19%.
Earnings released on 6 Nov 2025
EPS came in at -$0.16 surpassing the estimated -$0.26 by +38.46%, while revenue for the quarter reached $19.91m , missing expectations by -2.20%.
Earnings released on 7 Aug 2025
EPS came in at -$0.23 surpassing the estimated -$0.25 by +8.00%, while revenue for the quarter reached $19.56m , beating expectations by +10.26%.
Earnings released on 8 May 2025
EPS came in at -$0.28 surpassing the estimated -$0.29 by +3.45%, while revenue for the quarter reached $17.51m , missing expectations by -5.31%.
Earnings released on 5 Mar 2025
EPS came in at -$0.23 falling short of the estimated -$0.22 by -4.55%, while revenue for the quarter reached $19.07m , beating expectations by +3.10%.
Earnings released on 7 Nov 2024
EPS came in at -$0.22 surpassing the estimated -$0.23 by +4.35%, while revenue for the quarter reached $20.16m , missing expectations by -0.64%.
Earnings released on 1 Aug 2024
EPS came in at -$0.25 surpassing the estimated -$0.31 by +19.35%, while revenue for the quarter reached $21.37m , beating expectations by +3.19%.
Earnings released on 2 May 2024
EPS came in at -$0.33 falling short of the estimated -$0.29 by -13.79%, while revenue for the quarter reached $19.27m , missing expectations by -9.77%.
Earnings released on 7 Mar 2024
EPS came in at -$0.22 surpassing the estimated -$0.35 by +37.14%, while revenue for the quarter reached $18.75m , missing expectations by -0.95%.
Earnings released on 7 Nov 2023
EPS came in at -$0.27 surpassing the estimated -$0.31 by +12.90%, while revenue for the quarter reached $20.01m , beating expectations by +10.06%.
Earnings released on 3 Aug 2023
EPS came in at -$0.30 surpassing the estimated -$0.35 by +14.29%, while revenue for the quarter reached $23.47m , beating expectations by +8.71%.
Earnings released on 4 May 2023
EPS came in at -$0.35 surpassing the estimated -$0.41 by +14.63%, while revenue for the quarter reached $18.82m , missing expectations by -0.24%.
Earnings released on 13 Mar 2023
EPS came in at -$0.35 surpassing the estimated -$0.42 by +16.67%, while revenue for the quarter reached $20.54m , missing expectations by -6.79%.
Earnings released on 10 Nov 2022
EPS came in at -$0.46 surpassing the estimated -$0.47 by +2.13%, while revenue for the quarter reached $18.68m , missing expectations by -1.02%.
Earnings released on 11 Aug 2022
EPS came in at -$0.50 falling short of the estimated -$0.46 by -8.70%, while revenue for the quarter reached $17.23m , beating expectations by +6.27%.
Earnings released on 10 May 2022
EPS came in at -$0.49 falling short of the estimated -$0.41 by -19.51%, while revenue for the quarter reached $14.88m , beating expectations by +12.02%.
Earnings released on 24 Mar 2022
EPS came in at -$0.34 surpassing the estimated -$0.38 by +10.53%, while revenue for the quarter reached $14.69m , beating expectations by +3.61%.
Earnings released on 10 Nov 2021
EPS came in at -$0.43 falling short of the estimated -$0.38 by -13.16%, while revenue for the quarter reached $13.10m , beating expectations by +15.15%.
Earnings released on 12 Aug 2021
EPS came in at -$1.83 falling short of the estimated -$0.93 by -96.77%, while revenue for the quarter reached $12.54m , beating expectations by +9.96%.
SGHT Stock Performance
Access detailed SGHT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
